A one-step synthesis of 4-arylquinoline-2-carboxylates along with their antiprotozoal activity against the pathogenic parasite Toxoplasma gondii is reported. Mechanistic insights into the role of Lewis acid (silver triflate) versus Bronsted acid (triflic acid) catalysis are revealed clarifying aspects of the mechanism of the quinoline synthesis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c3ob41539b | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Discovery of potent anti-toxoplasmosis drugs from secondary metabolites in Citrus limon (lemon) leaves, supported in-silico study.
Sci Rep
January 2025
Department of Zoonotic Diseases, National Research Centre, Dokki, Giza, 12622, Egypt.
Toxoplasmosis induced by Toxoplasma gondii is a well-known health threat, that prompts fatal encephalitis increased with immunocompromised patients, in addition, it can cause chorioretinitis, microcephaly, stillbirth in the fetus and even led to death. Standard therapy uses sulfadiazine and pyrimethamine drugs revealed beneficial results during the acute stage, however, it has severe side effects. UPLC-ESI-MS/MS used to explore C.
View Article and Find Full Text PDFImmunomodulatory effect of propolis spp. in mice infected with .
Open Vet J
September 2024
Faculty of Veterinary Medicine, Universitas Airlangga, Kampus C Unair, Surabaya, Indonesia.
Background: Toxoplasmosis is a zoonotic disease caused by . Infection with virulent strains of induces excessive production of pro-inflammatory cytokines and increases fatality. Propolis has potential as an anti-inflammatory and immunomodulator.
View Article and Find Full Text PDFMolecular modelling and experimental validation identified a new therapeutic inhibitor of toxoplasmosis.
Comput Biol Med
December 2024
Laboratory of Sustainable Animal Environment Systems, Graduate School of Agricultural Sciences, Tohoku University, Japan. Electronic address:
Article Synopsis
- Toxoplasmosis, caused by the parasite Toxoplasma gondii, affects about one-third of humans, and there's a need for new treatments due to the lack of effective options.
- Researchers used computational methods to screen 3000 compounds, ultimately identifying nine candidate compounds that were tested against T. gondii in the lab.
- Among these, C5 showed promising anti-parasitic effects by inhibiting parasite growth and replication, while also increasing reactive oxygen species levels, although it exhibited some toxicity towards host cells as well.
Research progress of ubiquitin and ubiquitin-like signaling in Toxoplasma gondii.
Acta Trop
September 2024
Department of Parasitology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, PR China. Electronic address:
Toxoplasmosis, a zoonotic parasitic disease caused by Toxoplasma gondii (T. gondii), is prevalent worldwide. The fact should be emphasized that a considerable proportion of individuals infected with T.
View Article and Find Full Text PDFPyrimidine salvage in as a target for new treatment.
Front Cell Infect Microbiol
January 2024
School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Toxoplasmosis is a common protozoan infection that can have severe outcomes in the immunocompromised and during pregnancy, but treatment options are limited. Recently, nucleotide metabolism has received much attention as a target for new antiprotozoal agents and here we focus on pyrimidine salvage by as a drug target. Whereas uptake of [H]-cytidine and particularly [H]-thymidine was at most marginal, [H]-uracil and [H]-uridine were readily taken up.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!